Resources

Funding Opportunities

NIH Funding Opportunity: Aging and Pain

The National Institutes of Health (NIH) announces a call for Research Project Grant (R01) applications from institutions/organizations that propose to study biological, neurobiological, psychosocial, and clinical mechanisms and processes by which aging and/or age-related diseases affect the experience of pain; examine biological, neurobiological, psychosocial, and clinical factors that impact pain experience and prevalence in older people; evaluate existing pain assessment and/or management approaches in older adults; or develop new assessment methods and/or management strategies for pain with particular attention to the needs of older adults. Studies involving animal models or human subjects are appropriate under this program announcement.

This announcement encourages proposals to study the mechanisms and processes by which aging and/or age-related diseases and conditions affect the experience of pain, and to evaluate existing or new pain assessment methods and management approaches, especially in older adults. Studies may include molecular biological, biochemical, genetic, imaging, physiological, pathological, behavioral, social, clinical, and/or epidemiological approaches. For examples of research topics and approaches that may be considered as well as for more information, please visit grants.nih.gov/grants/guide/pa-files/PA-09-193.html.

National Institute of Arthritis and Musculoskeletal and Skin Diseases Announces Grant Program

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health, has issued a funding opportunity announcement (FOA), calling for applications for research awards designed to develop and evaluate new clinical trial outcomes measures to assess the adverse events, and the link between efficacy and effectiveness of therapies employed to treat diseases, illnesses and injuries of interest to the NIAMS. This FOA seeks to facilitate the development and initial evaluation of new clinically-relevant and patient-important outcome measures and instruments that could be further tested with existing or novel clinical trials designed to gain widespread acceptance and application in the diagnosis, treatment or cure of diseases, illnesses and injuries of interest to the NIAMS.

For more information please visit the NIH Web site.

Mesothelioma Research Grants

The Mesothelioma Applied Research Foundation announces the availability of its 2009 round of mesothelioma research grant funding. The application is open to all regions and closes August 15, 2009.

Continuing its efforts to stimulate translational research for the treatment of malignant mesothelioma, the Meso Foundation is again soliciting applications for funding of innovative projects that address issues for the treatment of the disease. Eligible projects may relate to benchwork, translational or clinical research, must not be presently funded or pending review, and may be conducted through any not-for-profit academic, medical or research institution, in the U.S. or abroad.

The Meso Foundation's ability to award grants results from the generosity of private donors, who give to the Foundation in order to make a direct impact on the tragedy of the disease. Therefore, the Foundation seeks exceptional projects for which the Foundation's funding is demonstrated to be essential and not duplicative.

The Meso Foundation's Science Advisory Board will review and score the research proposals, and make a recommendation to the Foundation's Board of Directors as to the relative ranking of the projects, and the extent to which they merit funding. The Foundation has historically been able to support an awards-to-applications percentage of approximately 25% reflecting the Foundation's deep commitment to funding highly deserving research. This round, the Foundation will again endeavor to fund as many high quality projects as its resources allow.

The award for any project will be for two years up to $50,000 per year. The Foundation will review and monitor the study's progress and results, requiring a ten month progress report, and a presentation and full progress report at the close of the second year. Funding will be continued for the second year only upon satisfactory progress obtained in the first year.

The National Mesothelioma Virtual Bank (NMVB) will provide facilitated access to the resource to Meso Foundation-funded researchers. They will receive expedited review of requests to use the NMVB, and at no cost they will have direct access to materials already in the bank, as well as enhanced collections from the main sites of materials not already in the bank which they need for their research.

Please be advised that the Meso Foundation does not pay institutional indirect costs.

Encouraged projects include, but are not limited to, benchwork/translational/clinical investigations of:

  1. Strategies for early detection of new or progressive disease;
  2. Definition of targetable differences between normal and transformed mesothelium and development of novel strategies for treatment taking advantage of these targets;
  3. Therapeutic intervention, including but not limited to;
    1. Gene therapy
    2. Immunotherapy
    4. Novel chemotherapeutic compounds
    5. Novel radiation techniques
    6. Novel mechanisms which inhibit angiogenesis or metalloproteinases
  4. Determination of clinical/molecular determinants for prognosis;
  5. Pain management.

Applications will be scored on the following criteria:

  1. Scientific merit
  2. Originality
  3. Study design
  4. Clinical or scientific impact
  5. Practicality and feasibility.

Clinical protocols and proposals involving animals must be approved by the appropriate IRB of the university, hospital, or institute before the Meso Foundation funds are awarded. A copy of either the approval letter(s) or of the request for approval must accompany the application.

Applications are limited to 10 pages (not including biographies) and are due no later than August 15, 2009. Notifications will begin December 15; awards will be activated by December 31, 2009.

To apply, mail an original application and six copies to:

Mesothelioma Applied Research Foundation
P.O. Box 91840
3944 State Street, Suite 340
Santa Barbara, CA 93190

Tel: 805/563-8400

In addition, e-mail a complete digital copy of the application to dmangone@curemeso.org. The original application must be deposited in the mail, and an e-mailed copy received by the Foundation on our prior to midnight, Pacific Daylight Time, on the application deadline, August 15th, 2009.

NIH Office of Extramural Research
Grants Home Page

grants1.nih.gov/grants/oer.htm

NINDS Grant Announcements

www.ninds.nih.gov/funding/ all_opps.htm?cluster_sort=2

International Association for the Study of Pain (IASP) Program of Grants and Awards

IASP has an extensive grants and awards program to support investigators working in basic or clinical research and to support education in developing countries. Visit the IASP Grants and Awards section of the IASP Web site for a list of available grants and awards.